Frankfurt - Delayed Quote EUR
Champions Oncology, Inc. (2I3.F)
5.15
-1.25
(-19.53%)
At close: May 2 at 3:29:01 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 12.01M | 14.67M | 56.6M | 61.02M |
| Low Estimate | 12.01M | 14.67M | 56.6M | 61.02M |
| High Estimate | 12.01M | 14.67M | 56.6M | 61.02M |
| Year Ago Sales | 14M | 14.06M | 50.16M | 56.6M |
| Sales Growth (year/est) | -14.20% | 4.30% | 12.85% | 7.80% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2I3.F | -- | -- | -- | -- |
| S&P 500 | 12.47% | 3.19% | 8.01% | 13.87% |
Upgrades & Downgrades
| Maintains | Craig-Hallum: Buy to Buy | 3/12/2025 |
| Maintains | Craig-Hallum: Buy to Buy | 12/12/2024 |
| Upgrade | Craig-Hallum: Hold to Buy | 9/12/2024 |
| Downgrade | Craig-Hallum: Buy to Hold | 3/13/2024 |
| Maintains | Roth MKM: Buy to Buy | 9/22/2023 |
| Maintains | Roth Capital: Buy | 3/15/2021 |
Related Tickers
VLA.VI Valneva SE
2.9320
+4.86%
38I.SG Intellia Therapeutics Inc
8.01
+16.05%
GLPG Galapagos NV
27.34
+2.09%
OLMA Olema Pharmaceuticals, Inc.
5.62
+6.24%
PYXS Pyxis Oncology, Inc.
1.2600
+14.55%
CRBU Caribou Biosciences, Inc.
0.8800
+9.75%
ARVN Arvinas, Inc.
7.72
+6.78%
REGN Regeneron Pharmaceuticals, Inc.
605.61
+2.65%